Research Snapshot: Researchers Identify Genes That Predict Pediatric AML Outcomes
UF researchers identified genes that were associated with resistance or sensitivity to chemotherapy and linked these with patients’ treatment outcomes.
UF-Developed Genetic Score Improves Outcomes by Personalizing Leukemia Therapy
Using patients’ own genetics to tailor their chemotherapy regimens appears to improve outcomes in children with acute myeloid leukemia, a pediatric cancer for which treatment has gone unchanged for 50 years, a new University of Florida Health-led study shows.
Genetic Score Advances Personalized Treatment Strategies With Promising AML Drug
In the latest development in precision medicine approaches to treating pediatric leukemia, UF Health researchers have developed a genetic score to predict patient outcomes with a promising targeted drug treatment.
